Dietary quercetin supplementation increases serum antioxidant capacity and alters hepatic gene expression profile in rats

Experimental Biology and Medicine

Volumn 236, Issue 6, 2011, Pages 701-706

  Zhao, Liting ^a,b   Wu, Jianquan ^a   Yang, Jijun ^a   Wei, Jingyu ^a   Gao, Weina ^a   Guo, Changjiang ^a  

^a INSTITUTE OF HEALTH AND ENVIRONMENTAL MEDICINE   (China)

^b MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

Antioxidant capacity; Gene expression; Liver; Quercetin; Rats

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; GLUTATHIONE; HOMOCYSTEINE; MALONALDEHYDE; QUERCETIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENERGY YIELD; FEEDING; GENE EXPRESSION PROFILING; HUMAN; IN VIVO STUDY; LIVER; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; RAT; SERUM;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; GENE EXPRESSION PROFILING; GLUTATHIONE; LIVER; MALONDIALDEHYDE; MICROARRAY ANALYSIS; QUERCETIN; RATS; RATS, WISTAR; SERUM; VITAMIN E;

RATTUS; RATTUS NORVEGICUS;

EID: 79958858748     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.010258     Document Type: Article

References (39)

1. Terao J. Dietary flavonoids as antioxidants. Forum Nutr 2009;61:87-94
2. Dias AS, Porawski M, Alonso M, Marroni N, Collado PS, Gonzalez-Gallego J. Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J Nutr 2005;135:2299-304
3. Nair MP, Mahajan S, Reynolds JL, Aalinkeel R, Nair H, Schwartz SA, Kandaswami C. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system. Clin Vaccine Immunol 2006;13:319-28
4. Chiang LC, Chiang W, Liu MC, Lin CC. In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids. J Antimicrob Chemother 2003;52:194-198
5. Neuhouser ML. Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer 2004; 50:1-7
6. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002;76:560-568
7. Mink PJ, Scrafford CD, Barraj LM, Harnack L, Hong CP, Nettleton JA, Jacobs DR Jr. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007;85:895-909
8. illiam RJ, Spencer JP, Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 2004;36:838-849
9. An D, Zhang Q, Wu SM, Wei JY, Yang JJ, Dong FT, Yan XZ, Guo CJ. Changes of metabolic profiles in urine after oral administration of quercetin in rats. Food Chem Toxicol 2010;48:1521-1527
10. Boomgaarden I, Egert S, Rimbach G, Wolffram S, Mü ller MJ, Döring F. Quercetin supplementation and its effect on human monocyte gene expression profiles in vivo. Br J Nutr 2010;26:1-10
11. Natsume Y, Kadota K, Satsu H, Shimizu M. Effect of quercetin on the gene expression profile of the mouse intestine. Biosci Biotechnol Biochem 2009;73:722-5
12. Angeloni D, Leoncini E, Malaguti M, Angelini S, Hrelia P, Hrelia S. Role of quercetin in modulating rat cardiomyocyte gene expression profile. Am J Physiol Heart Circ Physiol 2008;294:H1233-H1243
13. van der Woude H, Boersma MG, Vervoort J, Rietjens IMCM. Identification of 14 quercetin phase II mono- and mixed conjugates and their formation by rat and human phase II in vitro model systems. Chem Res Toxicol 2004;17:1520-1530
14. Bieger J, Cermak R, Blank R, de Boer VCJ, Hollman PCH, Kamphues J, Wolffram S. Tissue distribution of quercetin in pigs after long-term dietary supplementation. J Nutr 2008;138:1417-1420
15. Su JF, Guo CJ, Wei JY, Yang JJ, Jiang YG, Li YF. Protection against hepatic ischemia-reperfusion injury in rats by oral pretreatment with quercetin. Biomed Environ Sci 2003;16:1-8
16. Molina MF, Sanchez-Reus I, Iglesias I, Benedi J. Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress in mouse liver. Biol Pharm Bull 2003;26:1398-402
17. Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-1951
18. Ameho CK, Chen CYO, Smith D, Sanchez-Moreno C, Milbury PE, Blumberg JB. Antioxidant activity and metabolite profile of quercetin in vitamin E-depleted rats. J Nutr Biochem 2008;19:467-474
19. Benzie IFF, Strain JJ. The ferric reducing ability of plasma as a measure of 'antioxidant power': the FRAP assay. Anal Biochem 1996;239:70-76
20. Brewster MA, Turley CP. Vitamin C. In: Pesce AJ, Kaplan LA, eds. Methods in Clinical Chemistry. St Louis: The CV Mosby Company, 1987: 574-581
21. Hansen LG, Warwich WJ. An improved assay method for serum vitamin A and E using fluorometry. Am J Clin Pathol 1978;70:922-923
22. Ohkawa H, Ohishi N, Kunio Y. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8
23. Egert S, Wolffram S, Bosy-Westphal A, Boesch-saadatmandi C, Wagner AE, Frank J, Rimbach G, Mü ller MJ. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 2008;138:1615-1621
24. Igarashi K, Ohmuma M. Effects of isorhamnetin, rhamnetin, and quercetin on the concentrations of cholesterol and lipoperoxide in the serum and liver and on the blood and liver antioxidative enzyme activities of rats. Biosci Biotechnol Biochem 1995;59:595-601
25. Janisch KM, Williamson G, Needs P, Plumb GW. Properties of quercetin conjugates: modulation of LDL oxidation and binding to human serum albumin. Free Radic Res 2004;38:877-884
26. McAnlis GT, McEneny J, Pearce J, Young IS. Absorption and antioxidant effects of quercetin from onions in man. Eur J Clin Nutr 1999;53:92-96
27. Egert S, Boesch-Saadatmandi C, Wolffram S, Rimbach G, Mü ller MJ. Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J Nutr 2010;140:278-284
28. Shanely RA, Knab AM, Nieman DC, Jin F, McAnulty SR, Landram MJ. Quercetin supplementation does not alter antioxidant status in humans. Free Radic Res 2010;44:224-31
29. Jones PM, George AM. The ABC transporter structure and mechanism: perspectives on recent research. Cell Mol Life Sci 2004;61:682-699
30. Kim SR, Saito Y, Itoda M, Maekawa K, Kawamoto M, Kamatani N, Ozawa S, Sawada J. Genetic variations of the ABC transporter gene ABCB11 encoding the human bile salt export pump (BSEP) in a Japanese population. Drug Metab Pharmacokinet 2009;24:277-281
31. Tsuruoka S, Ishibashi K, Yamamoto H, Wakaumi M, Suzuki M, Schwartz GJ, Imai M, Fujimura A. Functional analysis of ABCA8, a new drug transporter. Biochem Biophys Res Commun 2002;298:41-545
32. Matsukawa N, Matsumoto M, Hara H. High biliary excretion levels of quercetin metabolites after administration of a quercetin glycoside in conscious bile duct cannulated rats. Biosci Biotechnol Biochem 2009;73:1863-1865
33. Mahley RW, Innerarity TL, Rall SC Jr, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984;25:1277-1294
34. Cromwell WC, Barringer TA. Low-density lipoprotein and apolipoprotein B: Clincal use in patients with coronary heart disease. Curr Cardiol Rep 2009;11:468-475
35. Day JR, Albers JJ, Gilbert TL, Whitmore TE, McConathy WJ, Wolfbauer G. Purification and molecular cloning of human apolipoprotein F. Biochem Biophys Res Commun 1994;203:1146-1151
36. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999;19:217-46
37. Boots AW, Kubben N, Haenen GRMM, Bast A. Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation. Biochem Biophys Res Commun 2003;308:560-565
38. Boots AW, Li H, Schins RPF, Duffin R, Heemskerk JWM, Bast A, Haenen GRMM. The quercetin paradox. Toxicol Appl Pharmacol 2007;222:89-96
39. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006;354:1578-1588